- Home
- BHC vs PRCT Comparison
BHC vs PRCT Comparison
Compare BHC & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHC
- PRCT
- Stock Information
- Founded
- BHC N/A
- PRCT 2009
- Country
- BHC Canada
- PRCT United States
- Employees
- BHC N/A
- PRCT N/A
- Industry
- BHC Biotechnology: Pharmaceutical Preparations
- PRCT Medical Specialities
- Sector
- BHC Health Care
- PRCT Health Care
- Exchange
- BHC Nasdaq
- PRCT Nasdaq
- Market Cap
- BHC 2.2B
- PRCT 2.0B
- IPO Year
- BHC N/A
- PRCT 2021
- Fundamental
- Price
- BHC $6.24
- PRCT $31.39
- Analyst Decision
- BHC Hold
- PRCT Strong Buy
- Analyst Count
- BHC 2
- PRCT 8
- Target Price
- BHC $9.00
- PRCT $59.00
- AVG Volume (30 Days)
- BHC 2.9M
- PRCT 1.7M
- Earning Date
- BHC 10-29-2025
- PRCT 11-04-2025
- Dividend Yield
- BHC N/A
- PRCT N/A
- EPS Growth
- BHC N/A
- PRCT N/A
- EPS
- BHC 0.97
- PRCT N/A
- Revenue
- BHC $10,029,000,000.00
- PRCT $299,907,000.00
- Revenue This Year
- BHC $6.81
- PRCT $48.38
- Revenue Next Year
- BHC $4.11
- PRCT $30.87
- P/E Ratio
- BHC $6.47
- PRCT N/A
- Revenue Growth
- BHC 5.86
- PRCT 50.07
- 52 Week Low
- BHC $4.25
- PRCT $27.80
- 52 Week High
- BHC $8.69
- PRCT $100.89
- Technical
- Relative Strength Index (RSI)
- BHC 47.14
- PRCT 48.22
- Support Level
- BHC $5.91
- PRCT $27.80
- Resistance Level
- BHC $6.15
- PRCT $32.52
- Average True Range (ATR)
- BHC 0.25
- PRCT 1.37
- MACD
- BHC -0.03
- PRCT 0.29
- Stochastic Oscillator
- BHC 32.55
- PRCT 70.54
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.